NEW YORK (GenomeWeb) — Courtagen Life Sciences will collaborate with Connecticut Children's Medical Center to identify alterations in genes associated with Autism Spectrum Disorder.

As part of the collaboration, Courtagen will use its targeted sequencing panel, DevSeek to genetically profile patients in the hospital's Autism Neurogenetics Clinic. Courtagen is a privately held genetic testing firm that offers next-generation sequencing and protein immunoassay testing for pediatric neurological disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.